Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Abstract Drug repurposing in cancer taps into the capabilities of existing drugs, initially designed for other ailments, as potential cancer treatments. It offers several advantages over traditional drug discovery, including reduced costs, reduced development timelines, and a lower risk of adverse e...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer
2024-09-01
|
| Seri Bilgileri: | Molecular Biomedicine |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s43556-024-00204-z |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|